NeuroPace (NPCE) Debt Ratio (2020 - 2026)
NeuroPace's quarterly Debt Ratio came in at 0.6 in Q1 2026, up 10.0% year-on-year from 0.54 in Q1 2025, and up 6.99% quarter-over-quarter from 0.56 in Q4 2025.
NeuroPace has reported Debt Ratio for 7 years, with the latest figure at 0.6 in Q1 2026.
- For the quarter ending Q1 2026, Debt Ratio rose 10.0% year-over-year to 0.6; the trailing twelve-month figure through Mar 2026 stood at 0.6 (up 10.0% YoY), and the FY2025 full-year result was 0.56, down 11.31% from the prior year.
- Debt Ratio for Q1 2026 stood at 0.6, up from 0.56 in the prior quarter.
- The five-year high for Debt Ratio was 0.63 in Q4 2024, with the low at 0.39 in Q1 2022.
- Average Debt Ratio over 5 years is 0.54, with a median of 0.55 recorded in 2025.
- Year-over-year, Debt Ratio tumbled 63.21% in 2022 and surged 30.51% in 2023.
- Tracing NPCE's Debt Ratio over 5 years: stood at 0.46 in 2022, then rose by 14.09% to 0.53 in 2023, then grew by 18.87% to 0.63 in 2024, then declined by 11.31% to 0.56 in 2025, then rose by 6.99% to 0.6 in 2026.
- The last three Debt Ratio figures came in at 0.6 (Q1 2026), 0.56 (Q4 2025), and 0.55 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.31 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.32 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.31 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.25 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.04 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.25 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.27 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.18 |
| 10 | NeuroPace | 558.86 Mn | 504.88 Mn | 18.05 Mn | 0.60 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.60 |
| Dec 31, 2025 | 0.56 |
| Sep 30, 2025 | 0.55 |
| Jun 30, 2025 | 0.55 |
| Mar 31, 2025 | 0.54 |
| Dec 31, 2024 | 0.63 |
| Sep 30, 2024 | 0.62 |
| Jun 30, 2024 | 0.63 |
| Mar 31, 2024 | 0.59 |
| Dec 31, 2023 | 0.53 |
| Sep 30, 2023 | 0.56 |
| Jun 30, 2023 | 0.54 |
| Mar 31, 2023 | 0.51 |
| Dec 31, 2022 | 0.46 |
| Sep 30, 2022 | 0.43 |
| Jun 30, 2022 | 0.43 |
| Mar 31, 2022 | 0.39 |
| Dec 31, 2021 | 0.37 |
| Sep 30, 2021 | 0.35 |
| Jun 30, 2021 | 0.34 |
| Mar 31, 2021 | 1.06 |
| Dec 31, 2020 | 0.94 |